FDA Clears Sulfadiazine Tablet for Sale Despite Safety Concerns

Summary

The US Food and Drug Administration (FDA) has made a determination that Sulfadiazine tablet, 500mg, was not withdrawn from sale due to safety or effectiveness concerns, despite previous worries about its potential risks.